Member Info for rebarm

The reason for the sp drop over the last couple of days is IMO logical. Future growth for FEVR will be overseas and strong marketing/sales initiatives driving that e.g. China. £ has shot up over the last two days and most companies dependent on overseas earnings have been hit. No conspiracy theory applies, again IMO, nothing more than a market reaction which probably presents the pi community with a buying opportunity

FYI, Turner Pope Investments are holding and investor's evening on Tuesday 19th Sept at which OPTI will be presenting. Contact brian@turnerpope.com for further information. Given recent announcements and more to come could be a useful forum to hear what SOH has to say about current progress. Unfortunately will be away but if anybody attends would appreciate feedback.

Matey, suspect you may be referring to my post of yesterday with your strident remark about LTH. Might be worth reading again and re-considering as I didn't define what I meant by 'long term'. After all 'long term' can refer to both the past and future. Hope you can work it out!

Chilting, tbh I haven't a clue! All developments in their pipeline are CTA or earlier. So many, many years before any reach licensing or approval stage and requiring significant additional funding. I believe I'm correct in suggesting that of clinical stage developments only about 1 or 2% reach the market so the chances of any Redx development making it is remote. However, if you check out their website there is some good material on those programmes and why I described RX005 is but one jewel. My plan is to wait for the Administrators to complete their work so we know exactly our position before deciding on what to do. Redx was always what I call one of my 'sleeper' holdings - interesting work, but long term so small investment - and if re-listed may just put them back to sleep again. Only my opinion of course and would urge you and any others reviewing their position to conduct some serious research before deciding what to do

Understandably significant negativity around recent events at Redx and, as an LTH, I empathise. However, having digested the recent Administrator's RNS, relevant articles and the posts on this board, great summary Boom, I am feeling more positive! Today our stake in Redx is worthless so a re-listing, which appears to be the Administrators goal, has some value to us. Probably limited but something is better than nothing. Not worth speculating what the sp might be at that point as still many twists and turns. RX005 has been described as the 'crown jewel'. IMO it is just one of a number of jewels. Further, to realise $40m for a programme that still hasn't got CTA is excellent. It hasn't started trials and is therefore years off approval with the need for significant funding downstream. What are the chances of it being successful? At this stage IMO very, very limited. Assuming the RX005 sale to LOXO is closed then current debts are cleared and cash is left in the bank (can't work out what that number is) to invest in other programmes. Undoubtedly further fund raising will be required but that is the nature of this sector. IMO Redx had too many programmes for a small operation with funding issues. We are left in a situation, therefore, where they can now focus on a smaller portfolio which I believe will result in improved focus and chances of success. Final point, we will never know the full detail of what has gone on so pointless speculating but the CFO has come in for much stick. Poor guy is only an interim so unlikely to have experienced anything like this. Tough place to be at the moment! Still a long way from success or seeing the sp in a place where a profit might be achievable.....dream on......but today I'm feeling more positive about the future for Redx.

Bruce, less than 20% of open offer taken up so you should get all you applied for

Bruce, no harm in folks doing some research for themselves!! Well aware thanks and as long as the sp stays at a reasonable level above the subscription price will be taking full advantage. Long way to go with this company but they are doing some great work

Sam, suspect that is standard wordage used by platform providers until such time as they have received formal details of placing/subscription. Covers them for all eventualities. As I suggested, check the RNSs and there is no mention of cash alternatives. Subscription is on the basis of 1 for 12 at a price of 37.5. My platform provider has opened another REDX line on my account specifically for this transaction and has the correct number of shares

Sam, the RNSs of 8th and 9th might help clarify the situation!

Good coverage of the placing and REDX research programmes on Proactive Investors. Includes an excellent interview with CEO Neil Murray

For information, somebody/s playing games! I made a fairly chunky purchase (for me!!) earlier today which appears as a sell. Interesting to know what other 'sells' are in fact buys and reasons why this is happening.

Many thanks Freddie for posting the Pharma Journal link. An excellent article - informative without being overly scientific. Major negative though, other than if the science works under trial conditions, are timescales. Long term takes on a whole new meaning!!

Boom, good point about potential need for further funding which unfortunately, if it happens, will push sp down even further. I think the other problem regarding sp is the perennial biotech/AIM issue on news. No news is interpreted as bad news and so the downward drift continues. REDX are not very good with communications despite what I believe to be excellent work in multiple fields. My biotech investment tends to follow research sectors so particularly interested in AB at the moment given the dire shortage of bacteria resistance currently on the market (for same reason also heavily into MTFB) and REDX appear to be doing some great work in this area and have strong partnerships with the NHS and AZN. I also like the way they've structured the company into a number of subsidiaries focused on specific research areas. They can concentrate on their specialist interests with less chance of distractions. Hate to admit it but sitting on a hefty loss at the moment but continue to add and believe this could come good over the long term Ivy, thanks for the post on the JP Morgan conference later this week. I didn't pick up on it until earlier this month and when I contacted the organiser about a ticket they responded that tickets would be allocated in a couple of weeks!! That would have taken us through to this week.....great organisation! I pushed back and suggested that leaving so late was a real problem for folks with calendars to manage. The response I got presumably from someone with 'manager' in their job title was arrogant in the extreme. Limited number of tickets, all went ages ago and the original response from them was just fine!! Charming! If either of you guys are going I would really appreciate any REDX highlights. Cheers

AUNBoy, try Business section p11!!!

There's life on this board!! Thanks Danny for Daily Mail pointer, a very positive article which hopefully will draw attention to the good work REDX is doing. This board has been a morgue no doubt due to lack of news and a share price that has had too close a relationship with gravity!!

Newswire from ProactiveInvestors yesterday lunchtime which quoted, 'Parsortix device will be the focus of a poster presentation at the American Association for Clinical Chemistry (AACC) annual meeting later today.' Surprising therefore that we haven't seen an RNS from AGL yet given how good/quick they are at releasing news. Certainly could do with something positive to stabilise the sp!

Dibs, you make a very valid point regarding FDA approval. I first invested in AGL early Jan last year after considerable research. What swung it for me was a clear statement from AN that FDA approval was expected within the next few months. This then slipped to Sept and now it could be any time but not soon!!. Despite having great confidence in what AGL is doing and having topped up on a number of occasions since my original investment I do feel AN is prone to a bit of spin. If you look at his frequent interviews he rarely gives a serious/straight answer although the questions coming from the likes of Proactive Investors could never be described as searching!!

Given the recent excellent news why the sp drop? Makes no sense

Anybody hazard a guess as to why the sp should drop into negative territory after such excellent news earlier?

Thanks jupiter. A useful interview and a pleasant change from the lack of information which has, unfortunately, been typical of REDX